Phase 2 Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a confirmed diagnosis of Cystic Fibrosis
- You are either not eligible for CFTR modulator therapy (a specific type of Cystic Fibrosis medication), or you have not been taking CFTR modulators for at least 60 days before the study begins — for example, because of side effects, the medication not working well for you, or not being able to access it
- Your lung function test result (called FEV1) falls within a specific range — between 40% and 100% of the expected value for your age, sex, and height (or 45% to 90% for one particular group in the study)
Who may not be able to join:
- You have a history of a serious illness or medical condition that could increase your risk of harm or make it harder to evaluate the study results (confirm with trial site)
- You have recently coughed up a significant amount of blood (confirm with trial site for what counts as "recent" or "significant")
- You have had a major surgical procedure recently (confirm with trial site for timeframe)
- You have had an organ transplant (such as a lung, liver, or kidney) or a blood/bone marrow transplant
- You need extra oxygen during the day, or need more than 2 litres per minute of oxygen while sleeping
- You are taking high daily doses of steroid tablets (such as prednisone) on an ongoing basis — specifically more than 15 mg per day or 30 mg every other day
- Your liver or kidney function does not meet the required levels as shown by blood tests
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 858-900-2660
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence, severity and dose relationship of adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.